| scholarly article | Q13442814 |
| P2093 | author name string | Gennadiy Moiseyev | |
| Jian-Xing Ma | |||
| Krysten M Farjo | |||
| Rafal A Farjo | |||
| Stacey Halsey | |||
| P2860 | cites work | Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes | Q24309211 |
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Overview of retinoid metabolism and function | Q28026612 | ||
| Evidence for an essential role of megalin in transepithelial transport of retinol | Q28141555 | ||
| Retinopathy in diabetes | Q28166601 | ||
| A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A | Q28285192 | ||
| A major role for VCAM-1, but not ICAM-1, in early atherosclerosis | Q28365883 | ||
| Activation of interleukin-6 gene expression through the NF-kappa B transcription factor | Q28646310 | ||
| Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes | Q30769310 | ||
| Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone | Q33946318 | ||
| Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects | Q34538317 | ||
| Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects | Q34590320 | ||
| Diabetes and atherosclerosis: epidemiology, pathophysiology, and management | Q34646074 | ||
| Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses | Q34693808 | ||
| Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. | Q35085027 | ||
| Adipose tissue dysregulation in patients with metabolic syndrome | Q35497928 | ||
| Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. | Q35540861 | ||
| Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism | Q35943971 | ||
| Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases | Q36408698 | ||
| Redox signaling in angiogenesis: role of NADPH oxidase | Q36509981 | ||
| Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy | Q37084522 | ||
| Retinol to retinol-binding protein (RBP) is low in obese adults due to elevated apo-RBP. | Q37217241 | ||
| Role of NADPH oxidase in retinal vascular inflammation. | Q37233106 | ||
| Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. | Q37241344 | ||
| NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology | Q37265507 | ||
| Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion | Q37353803 | ||
| Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. | Q37400719 | ||
| Role of NADPH oxidase in atherosclerosis | Q37445914 | ||
| Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. | Q37466109 | ||
| Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells | Q38290808 | ||
| Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. | Q38501870 | ||
| Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation | Q40236661 | ||
| RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle. | Q40345737 | ||
| Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. | Q40402637 | ||
| Differential nitric oxide production by microvascular and macrovascular endothelial cells | Q41101353 | ||
| Role of nuclear factor-kappa B in atherogenesis | Q41454318 | ||
| Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
| Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus | Q41648901 | ||
| Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. | Q41941165 | ||
| Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases | Q42449747 | ||
| Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. | Q42454519 | ||
| Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness | Q42910713 | ||
| Serum retinol-binding protein 4 levels in patients with diabetic retinopathy | Q43127549 | ||
| Microvascular and macrovascular endothelial cells produce different constrictor substances | Q44360913 | ||
| Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study | Q44680472 | ||
| Retinol-binding protein 4 and insulin resistance in preeclampsia | Q44793379 | ||
| Endothelial dysfunction | Q45000505 | ||
| Retinol-binding protein-4 in women with untreated essential hypertension. | Q45952187 | ||
| Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly | Q46065230 | ||
| RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. | Q46122914 | ||
| Recombinant human retinol-binding protein refolding, native disulfide formation, and characterization | Q46221827 | ||
| Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study | Q46511404 | ||
| Serum retinol binding protein 4 is related to insulin resistance and nonoxidative glucose metabolism in lean and obese women with normal glucose tolerance. | Q46631368 | ||
| Circulating retinol-binding protein 4 and metabolic syndrome in the elderly. | Q51375913 | ||
| Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. | Q51463161 | ||
| Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. | Q51464733 | ||
| Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity | Q58197140 | ||
| Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects | Q79759732 | ||
| Retinol binding protein-4 levels and clinical features of type 2 diabetes patients | Q80171630 | ||
| Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity | Q80499723 | ||
| Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis | Q80672548 | ||
| TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells | Q83159167 | ||
| High plasma retinol binding protein 4 (RBP4) is associated with systemic inflammation independently of low RBP4 adipose expression and is normalized by transplantation in nonobese, nondiabetic patients with chronic kidney disease | Q83972667 | ||
| Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction | Q84759975 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| endothelium | Q111140 | ||
| P304 | page(s) | 5103-5115 | |
| P577 | publication date | 2012-10-15 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism | |
| P478 | volume | 32 |
| Q34834337 | A genetic polymorphism in RBP4 is associated with coronary artery disease |
| Q89000215 | A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle |
| Q39734472 | Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice |
| Q36920864 | Adipokines mediate inflammation and insulin resistance |
| Q42566152 | Apo-RBP, holo-RBP, and insulin resistance |
| Q92977975 | Association between new circulating proinflammatory and anti-inflammatory adipocytokines with coronary artery disease |
| Q40269808 | Association of RBP4 genetic variants with childhood obesity and cardiovascular risk factors |
| Q28534795 | Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients |
| Q47216784 | Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update |
| Q41897708 | Characterization of Vitreous and Aqueous Proteome in Humans With Proliferative Diabetic Retinopathy and Its Clinical Correlation |
| Q26744760 | Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology |
| Q51277737 | Correlation of crevicular fluid and serum levels of retinol-binding protein 4 and leptin in chronic periodontitis and obesity. |
| Q91954772 | Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis |
| Q37643950 | Downregulation of STRA6 in adipocytes and adipose stromovascular fraction in obesity and effects of adipocyte-specific STRA6 knockdown in vivo |
| Q58748857 | Elevated RBP4 plasma levels were associated with diabetic retinopathy in type 2 diabetes |
| Q58748879 | Evaluation of serum retinol-binding protein-4 levels as a biomarker of poor short-term prognosis in ischemic stroke |
| Q39545975 | How free retinol behaves differently from rbp-bound retinol in RBP receptor-mediated vitamin A uptake |
| Q37734337 | Identification of Tengfu Jiangya Tablet Target Biomarkers with Quantitative Proteomic Technique |
| Q50908478 | Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry. |
| Q91711447 | Inflammatory Signaling and Brown Fat Activity |
| Q58773048 | Involvement of RBP4 in Diabetic Atherosclerosis and the Role of Vitamin D Intervention |
| Q46576127 | Kaempferol inhibits the production of ROS to modulate OPN-αvβ3 integrin pathway in HUVECs |
| Q89870839 | Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients |
| Q27318848 | Novel role for retinol-binding protein 4 in the regulation of blood pressure |
| Q38744248 | Protective effects of resveratrol and its analogs on age-related macular degeneration in vitro. |
| Q35617398 | Relationship between Proinflammatory and Antioxidant Proteins with the Severity of Cardiovascular Disease in Type 2 Diabetes Mellitus |
| Q36920540 | Retinol and retinyl esters: biochemistry and physiology |
| Q35126137 | Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis |
| Q28082224 | Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseases |
| Q90192541 | Retinol-Binding Protein 4 Accelerates Metastatic Spread and Increases Impairment of Blood Flow in Mouse Mammary Gland Tumors |
| Q90378365 | Retinol-Binding Protein 4 Predicts Lesion Volume (Determined by MRI) and Severity of Acute Ischemic Stroke |
| Q90485323 | Retinol-binding protein 2 (RBP2) binds monoacylglycerols and modulates gut endocrine signaling and body weight |
| Q37264404 | Retinol-binding protein 4 and its membrane receptor STRA6 control adipogenesis by regulating cellular retinoid homeostasis and retinoic acid receptor α activity |
| Q55279060 | Serum Carotenoids Are Inversely Associated with RBP4 and Other Inflammatory Markers in Middle-Aged and Elderly Adults. |
| Q34145836 | Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease |
| Q91670775 | Serum retinol-binding protein 4 is associated with the presence and severity of coronary artery disease in patients with subclinical hypothyroidism |
| Q37729999 | Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. |
| Q41440776 | Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration |
| Q35868411 | Transgenic Mice Overexpressing Serum Retinol-Binding Protein Develop Progressive Retinal Degeneration through a Retinoid-Independent Mechanism |
| Q35532291 | Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice |
| Q26783584 | Vitamin A Transport Mechanism of the Multitransmembrane Cell-Surface Receptor STRA6 |
| Q55265742 | Vitreous levels of apolipoprotein A1 and retinol binding protein 4 in human rhegmatogenous retinal detachment associated with choroidal detachment. |
Search more.